JOHNDELL DIRECTO: Open Payments
NPI 1881388379 · ARCADIA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 43 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $1,162 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $228 |
| Otsuka America Pharmaceutical, Inc. | 4 | $176 |
| Neurocrine BioSciences, Inc. | 8 | $170 |
| E.R. Squibb & Sons, L.L.C. | 12 | $166 |
| Vanda Pharmaceuticals Inc. | 4 | $82 |
| Alkermes, Inc. | 4 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: AUSTEDO XR, REXULTI, INGREZZA, COBENFY, FANAPT, LYBALVI, CAPLYTA, UZEDY.
Industry payments across FL — which companies pay providers there.
